Peter Wilker

Assistant Professor
Year hired: Fall 2012



Saint Olaf College, 1996.  B.A. Biology
University of Minnesota-Twin Cities, 2002.  M.P.H. Epidemiology
Washington University in Saint Louis, 2008.  Ph.D. Immunology
University of Wisconsin-Madison, 2008-2012. Postdoctoral Fellow

Courses taught:

Immunology Laboratory (Mic 406/506)
Fundamentals of Microbiology Laboratory (Mic 230)

Research Interests:

Immunology of influenza viruses
Animal models of influenza
Viral adaptation and transmission dynamics


Spending time with my family, watching football, grilling meat and the occasional vegetable, avoiding yard work

Recent Publications:

Smith, K.E., Wilker, P.R., Reiter, P., Hedican, E.B., Bender, J.B., and Hedberg, C.W.  (2012). Antibiotic Treatment of Escherichia coli O157 Infection and the Risk of the Hemolytic Uremic Syndrome, Minnesota.   Pediatr Infect Dis J 31, 37-41.

Walsh, K.B., Teijaro, J.R., Wilker, P.R., Jatzek, A., Fremgen, D.M., Das, S.C., Watanabe, T., Hatta, M., Shinya, K., Suresh, M., et al. (2011). Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci USA 108, 12018-12023.

Kohyama, M., Ise, W., Edelson, B.T., Wilker, P.R., Hildner, K., Mejia, C., Frazier, W.A., Murphy, T.L., and Murphy, K.M. (2009). Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 457, 318-321.

Wilker, P.R., Kohyama, M., Sandau, M.M., Albring, J.C., Nakagawa, O., Schwarz, J.J., and Murphy, K.M. (2008). Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation. Nat Immunol 9, 603-612.

Wilker, P.R., Sedy, J.R., Grigura, V., Murphy, T.L., and Murphy, K.M. (2007). Evidence for carbohydrate recognition and homotypic and heterotypic binding by the TIM family. Int Immunol 19, 763-773.
Bougie, D.W., Wilker, P.R., and Aster, R.H. (2006). Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies. Blood 108, 922-927.

Bougie, D.W., Wilker, P.R., Wuitschick, E.D., Curtis, B.R., Malik, M., Levine, S., Lind, R.N., Pereira, J., and Aster, R.H. (2002). Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 100, 2071-2076.

Cunha, P.D., Lord, R.S., Johnson, S.T., Wilker, P.R., Aster, R.H., and Bougie, D.W. (2000). Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug. Transfusion 40, 663-668.